Question follow-through · 113100
Fluorinated Gases: Medical Equipment
To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment her Department has made of the potential adverse impact of exempting Metered Dose Inhalers (MDIs) from its F gas phasedown plans.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department for Environment, Food and Rural Affairs
- Tabled
- 12 Feb 2026
- Target answer date
- 26 Feb 2026
- Answer
- 26 Feb 2026 · 14 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Taxation (Energy and Vehicles) Bill Committee: New Clause 5 · 1 Jul 2026
- Taxation (Energy and Vehicles) Bill Committee: New Clause 4 · 1 Jul 2026
- Taxation (Energy and Vehicles) Bill Committee: New Clause 2 · 1 Jul 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
12 Feb 2026
Question tabled
To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment her Department has made of the potential adverse impact of exempting Metered Dose Inhalers (MDIs) from its F gas phasedown plans.
26 Feb 2026
Target answer date
Date supplied by the official written-questions record.
26 Feb 2026
Answer published
As stated in last year’s consultation on the proposal for HFC phasedown reform, the UK Government, in collaboration with the Scottish and Welsh Governments, is committed to further exploring areas for F gas reform considered out of scope of the consultati...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.